Finance · Deals
Malaysia Hospital Group A1Health Prepares US$1.7 Billion IPO for Early 2027
Asia OneHealthcare, owned by Hong Leong and TPG, eyes RM30 billion valuation in what could become the country's largest healthcare listing

KEY TAKEAWAYS
- ·Asia OneHealthcare plans to raise RM7 billion to RM7.5 billion in a Malaysian IPO targeted for Q1 2027, aiming for a RM30 billion valuation.
- ·The hospital group operates 23 facilities across Malaysia and Vietnam and is jointly owned by Hong Leong Group and TPG Capital.
- ·Private equity firms view hospital IPOs as attractive exits due to aging demographics, rising incomes, and growing private healthcare demand in Southeast Asia.
Record-Sized Healthcare Exit Takes Shape
Asia OneHealthcare, the regional hospital operator backed by Malaysian tycoon Quek Leng Chan and US private equity firm TPG, is preparing to raise between RM7 billion and RM7.5 billion (US$1.7 billion to US$1.9 billion) through a Malaysian initial public offering slated for the first quarter of 2027, according to sources with knowledge of the matter.
The company plans to file IPO documentation in November 2026, according to the source. The offering would value the hospital group at approximately RM30 billion, positioning it as potentially the largest healthcare listing in Malaysia's history.
A1Health, formerly operating under the Columbia Asia Healthcare brand, currently runs 23 private hospitals across Malaysia and Vietnam. The group has been under the joint ownership of Quek's Hong Leong conglomerate and TPG Capital, which have been restructuring and expanding the platform since acquisition.
The Private Equity Playbook in Healthcare
The timing reflects a broader strategy among private equity investors targeting healthcare assets in Southeast Asia. Hospital operators present what fund managers consider a straightforward investment thesis: rising incomes, aging populations, and sustained growth in private healthcare spending create predictable demand trajectories that translate well to public market investors.
For TPG, the A1Health exit would mark another significant realization in its Asia healthcare portfolio. The firm has been active in the sector across the region, betting on the shift from public to private healthcare as middle-class expansion accelerates.
Hong Leong's involvement underscores the group's longstanding presence in Malaysian healthcare infrastructure. Quek Leng Chan, one of Southeast Asia's most prominent business figures, has built a diversified empire spanning banking, property, manufacturing, and now healthcare services.
Malaysia's Healthcare Landscape
The proposed valuation places A1Health in direct comparison with IHH Healthcare, the region's largest private hospital operator, which runs chains including Parkway Pantai in Singapore and Malaysia, Acibadem in Turkey, and Gleneagles hospitals. IHH itself was spun out of Malaysian conglomerate Sime Darby in 2012 and dual-listed in Kuala Lumpur and Singapore.
Malaysia's private healthcare sector has been expanding steadily, driven by both domestic demand and medical tourism. The country has positioned itself as a lower-cost alternative to Singapore for complex procedures, attracting patients from Indonesia, the Middle East, and other parts of Asia.
If A1Health achieves its targeted valuation, the listing would also represent one of the largest IPOs in Malaysia in recent years, providing a test case for investor appetite in the region's equity markets. Malaysian IPO activity has been uneven, with several large offerings delayed or scaled back due to market volatility.
What Comes Next
The November filing timeline suggests underwriters will be appointed in the coming weeks. Investment banks active in Southeast Asian healthcare deals are expected to compete for lead roles on the transaction.
The success of the IPO will depend on market conditions in early 2027 and investor confidence in Malaysia's economic trajectory. Healthcare assets generally trade at premium valuations in Asia, but recent volatility in regional equity markets has forced several issuers to recalibrate pricing expectations.
For now, A1Health is moving forward with preparations, betting that the structural drivers behind private healthcare demand will outweigh any near-term market turbulence.
RELATED STORIES
Spot something wrong? Email editor@briefasia.com. We log every correction publicly.



